Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
44.05
-2.80 (-5.98%)
May 5, 2025, 4:00 PM EDT - Market closed

Guardant Health Statistics

Total Valuation

Guardant Health has a market cap or net worth of $5.46 billion. The enterprise value is $6.07 billion.

Market Cap 5.46B
Enterprise Value 6.07B

Important Dates

The last earnings date was Wednesday, April 30, 2025, after market close.

Earnings Date Apr 30, 2025
Ex-Dividend Date n/a

Share Statistics

Guardant Health has 123.89 million shares outstanding. The number of shares has increased by 5.60% in one year.

Current Share Class 123.89M
Shares Outstanding 123.89M
Shares Change (YoY) +5.60%
Shares Change (QoQ) +0.09%
Owned by Insiders (%) 4.37%
Owned by Institutions (%) 92.72%
Float 112.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.02
Forward PS 5.92
PB Ratio -21.76
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.84
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.11

Current Ratio 4.11
Quick Ratio 3.61
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -166.70

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -18.64%
Return on Invested Capital (ROIC) -22.99%
Return on Capital Employed (ROCE) -40.64%
Revenue Per Employee $382,977
Profits Per Employee -$206,109
Employee Count 2,021
Asset Turnover 0.51
Inventory Turnover 4.27

Taxes

In the past 12 months, Guardant Health has paid $1.17 million in taxes.

Income Tax 1.17M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +133.32% in the last 52 weeks. The beta is 1.49, so Guardant Health's price volatility has been higher than the market average.

Beta (5Y) 1.49
52-Week Price Change +133.32%
50-Day Moving Average 43.70
200-Day Moving Average 34.58
Relative Strength Index (RSI) 47.02
Average Volume (20 Days) 2,515,129

Short Selling Information

The latest short interest is 7.62 million, so 6.15% of the outstanding shares have been sold short.

Short Interest 7.62M
Short Previous Month 8.28M
Short % of Shares Out 6.15%
Short % of Float 6.80%
Short Ratio (days to cover) 4.11

Income Statement

In the last 12 months, Guardant Health had revenue of $774.00 million and -$416.55 million in losses. Loss per share was -$3.38.

Revenue 774.00M
Gross Profit 474.77M
Operating Income -454.58M
Pretax Income -490.27M
Net Income -416.55M
EBITDA -412.67M
EBIT -454.58M
Loss Per Share -$3.38
Full Income Statement

Balance Sheet

The company has $698.57 million in cash and $1.31 billion in debt, giving a net cash position of -$607.81 million or -$4.91 per share.

Cash & Cash Equivalents 698.57M
Total Debt 1.31B
Net Cash -607.81M
Net Cash Per Share -$4.91
Equity (Book Value) -250.79M
Book Value Per Share -2.03
Working Capital 701.27M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$272.26 million and capital expenditures -$32.61 million, giving a free cash flow of -$304.87 million.

Operating Cash Flow -272.26M
Capital Expenditures -32.61M
Free Cash Flow -304.87M
FCF Per Share -$2.46
Full Cash Flow Statement

Margins

Gross margin is 61.34%, with operating and profit margins of -58.73% and -53.82%.

Gross Margin 61.34%
Operating Margin -58.73%
Pretax Margin -53.67%
Profit Margin -53.82%
EBITDA Margin -53.32%
EBIT Margin -58.73%
FCF Margin n/a

Dividends & Yields

Guardant Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.60%
Shareholder Yield -5.60%
Earnings Yield -7.63%
FCF Yield -5.59%
Dividend Details

Analyst Forecast

The average price target for Guardant Health is $52.33, which is 18.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target $52.33
Price Target Difference 18.80%
Analyst Consensus Strong Buy
Analyst Count 21
Revenue Growth Forecast (5Y) 19.74%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Guardant Health has an Altman Z-Score of -1.28 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.28
Piotroski F-Score 4